Clinical Trial Update: The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating MC2-25 Cream for chronic kidney disease-associated pruritus has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease-associated Pruritus

Drugs mentioned

• MC2-25 Cream (MC2-25)

Snippet

Sponsor: MC2 Therapeutics | Conditions: Chronic Kidney Disease-associated Pruritus | Phase 2 | Status: COMPLETED | Results posted: 2025-03-17